Soft tissue and bone sarcomas are a rare and heterogeneous form of cancer. With standard
of care treatment options including surgery, radiation, and chemotherapy, the long‐term …

Sarcomas are seen as mixed-up nature with genetic and transcriptional heterogeneity and
poor prognosis. Although the genes involved in ferroptosis are still unclear, iron loss is …

Sarcoma is a rare and an extremely aggressive form of cancer that originates from
mesenchymal cells. Pyroptosis exerts a dual effect on tumours by inhibiting tumour cell …

Rare types of cancer are often not effectively treated by approaches such as chemotherapy
and radiotherapy, although their side-effects persist. Immunotherapy has been gaining …

Introducción: En el momento actual, los tumores sólidos refractarios al tratamiento
convencional constituyen la principal causa de muerte en la edad pediátrica. Por tanto, es …

8. Abdollahi MR, Memari HR, van Wijnen AJ. Factor affecting the endogenous (beta)-
glucuronidase activity in rapeseed haploid cells: How to avoid interference with the Gus …

Objective: By mining the TCGA database to look for immunotherapy targets of soft tissue
sarcoma, and analyzed their biological behavior. Methods: The data of 265 samples were …

Sarcoma is a rare and an extremely aggressive form of cancer that originates from
mesenchymal cells. Pyroptosis exerts a dual effect on tumours by inhibiting tumour cell …